Hostname: page-component-6bb9c88b65-kzqxb Total loading time: 0 Render date: 2025-07-23T13:54:32.390Z Has data issue: false hasContentIssue false
  • English
  • Français

Comment on “dealing With Discounting”

Published online by Cambridge University Press:  10 March 2009

Magnus Johannesson  and
Lars-Ake Levin
Magnus Johannesson
Affiliation:
Department of Health and Society, Linkoping University, 581 83 Linköping, Sweden
Lars-Ake Levin
Affiliation:
Department of Health and Society, Linkoping University, 581 83 Linköping, Sweden
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Letters to the Editors
Information
International Journal of Technology Assessment in Health Care , Volume 7 , Issue 4 , Fall 1991 , pp. 651 - 653
Copyright
Copyright © Cambridge University Press 1991

References

1.Beck, J. R., Kassirer, J. P., & Pauker, S. G.A convenient approximation of life expectancy; The “DEALE.” American Journal of Medicine, 1982, 73, 863–97.CrossRefGoogle ScholarPubMed
2.Drummond, M. F., Stoddart, G. L., & Torrance, G. W.Methods for the economic evaluation of health care programmes. Oxford, U.K.: Oxford University Press, 1987.Google Scholar
3.Johannesson, M., & Jönsson, B. Cost-effectiveness analysis of hypertension treatment — Methodological issues. CMT Report, Linköping, Sweden: Linköping University Center for Medical Technology Assessment, 1990, 5.Google Scholar
4.Keeler, E., & Cretin, S.Discounting of life savings and other non-monetary effects. Management Science, 1983, 29, 300–06.CrossRefGoogle Scholar
5.Martens, L., & Van Doorslaer, E.Dealing with discounting: An application to the cost-effectiveness of intracoronary thrombolysis with streptokinase. International Journal of Technology Assessment in Health Care, 1990, 6, 139–45.CrossRefGoogle Scholar
6.Rosen, S.The value of changes in life expectancy. Journal of Risk and Uncertainty, 1988, 1, 285–304.CrossRefGoogle Scholar
7.Vermeer, F., Simoons, M. L., de Swaan, C., et al. Cost-benefit analysis of early thrombolytic treatment with intracoronary streptokinase. British Heart Journal, 1988, 59, 527–34.CrossRefGoogle ScholarPubMed
8.Weinstein, M. C., & Stason, W. B.Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1977, 296, 716–21.CrossRefGoogle ScholarPubMed